An interventional study of Routine Health Education in Health Literacy and Breast Cancer Awareness, sponsored by Buca Seyfi Demirsoy State Hospital. Not yet recruiting. Open to female participants aged 18 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-20.
Sponsored by Buca Seyfi Demirsoy State Hospital · Not applicable, Interventional, and Health services research
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Objective: This study aims to evaluate the effectiveness of the "Teach Back" technique in increasing breast cancer knowledge among women with limited health literacy.
Method: This research is a randomized controlled experimental study. The study is planned to be conducted with individuals who applied to the KETEM unit of Healthy Life Center No. 1, affiliated with the Karabağlar District Health Directorate in İzmir.
Data will be evaluated for normality; dependent samples t-test will be used for pre- and post-education comparisons, and Wilcoxon signed-rank test will be used if normality is not achieved. Baseline differences between the experimental and control groups will be analyzed with independent samples t-test or Mann-Whitney U test, and categorical variables will be analyzed with the Chi-square test. In the study, the experimental group will receive breast cancer education in groups of 5, consisting of 20-minute sessions with a 4-week interval, presented in simple language avoiding medical jargon, and the education content will be re-explained by the participants in their own words. These sessions will consist of general content such as breast cancer risk factors, symptoms, and the importance of early diagnosis.
The control group will be educated using existing educational materials used by the Ministry of Health. The content of these trainings will consist of topics such as breast cancer risk factors, symptoms, and the importance of early diagnosis. The Teach Back technique will not be applied to the control group.
Objective: This study aims to evaluate the effectiveness of the "Teach Back" technique in increasing breast cancer knowledge among women with limited health literacy.
Method: This research is a randomized controlled experimental study. The study is planned to be conducted with individuals who applied to the KETEM unit of Healthy Life Center No. 1, affiliated with the Karabağlar District Health Directorate in İzmir.
Data will be evaluated for normality; dependent samples t-test will be used for pre- and post-education comparisons, and Wilcoxon signed-rank test will be used if normality is not achieved. Baseline differences between the experimental and control groups will be analyzed with independent samples t-test or Mann-Whitney U test, and categorical variables will be analyzed with the Chi-square test. In the study, the experimental group will receive breast cancer education in groups of 5, consisting of 20-minute sessions with a 4-week interval, presented in simple language avoiding medical jargon, and the education content will be re-explained by the participants in their own words. These sessions will consist of general content such as breast cancer risk factors, symptoms, and the importance of early diagnosis.
The control group will be educated using existing educational materials used by the Ministry of Health. The content of these trainings will consist of topics such as breast cancer risk factors, symptoms, and the importance of early diagnosis. The Teach Back technique will not be applied to the control group.
14,832 studies on the registry are indexed under Breast Neoplasms; 3,320 are open to participants now.
This study's planned enrollment of 80 is above the median of 72 across 10,903 interventional studies indexed under Breast Neoplasms.
Browse Breast Neoplasms studies →Buca Seyfi Demirsoy State Hospital is the lead sponsor of 3 studies on the registry; 2 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Women over 18 years of age,
Exclusion Criteria:
Participants receive structured individual breast cancer awareness and screening education delivered using the Teach-Back method.
Other: Routine Health Education
Participants receive standard breast cancer awareness and screening education provided through routine health center procedures.
Structured individual health education on breast cancer screening and awareness delivered using the Teach-Back method to ensure comprehension among participants with low health literacy.
Also known as: Teach-Back Method Education, Standard Care Education
Change in Breast Cancer Knowledge Level
Assessed using the Knowledge Scale for Breast Cancer and Screening Methods (GKMKBT). Total scores range from 0 to 44, with higher scores indicating greater knowledge regarding breast cancer and screening procedures.
Time frame: Baseline (pre-intervention) and 1 month post-intervention
Change in Health Literacy Level
Assessed using the Turkey Health Literacy Scale-32 (TSOY-32). Scores range from 0 to 50, where higher scores represent higher health literacy levels.
Time frame: Baseline (pre-intervention) and 1 month post-intervention
No study locations are listed for this record.
Plan to share: No — Individual participant data will not be shared to protect participant privacy and maintain confidentiality, as explicit consent for secondary data sharing was not obtained from participants under the approved study protocol.
No publications or documents are linked to this record.
Start is estimated for Sep 2026; primary completion for Jun 2027, 9 months later.
Of 2,663 non-industry interventional studies with no phase under Breast Neoplasms, half reached primary completion within 33 months of starting (the median), counting those still running; a quarter within 16 and three quarters within 66. This study's planned 9 months is below that.
Counting every sponsor, half of 2,773 studies reached it within 33 months; a quarter within 15 and three quarters within 66.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Buca Seyfi Demirsoy State Hospital